Veru (VERU) Net Income (2012 - 2026)
Veru (VERU) posted quarterly Net Income of $351418.0 for Q1 2026, up 813.89% year-over-year from $38453.1 in Q1 2025, and up 135.27% quarter-over-quarter from $149367.0 in Q3 2025.
Veru (VERU) Net Income (2012 - 2026) Analysis & Trends
Veru (VERU) has reported Net Income for 15 consecutive years, with $351418.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income rose 813.89% year-over-year to $351418.0; the TTM figure through Mar 2026 stood at $491066.0 (up 106.3% YoY), while the FY2025 annual figure was -$7.0 million, down 177.2% from the prior year.
- Net Income grew to $351418.0 in Q1 2026 per VERU's latest filing, from $149367.0 in the prior quarter.
- Across five years, Net Income topped out at $351418.0 in Q1 2026 and bottomed at -$42.2 million in Q3 2022.
- Historically, Net Income has averaged -$10.4 million across 5 years, with a median of -$4.2 million in 2024.
- Annual changes were most pronounced in 2022 — Net Income tumbled 1211.42% — and 2026, when it soared 813.89%.
- Veru's Net Income stood at -$30.6 million in 2022, then jumped by 98.01% to -$608598.0 in 2023, then tumbled by 1072.44% to -$7.1 million in 2024, then soared by 102.09% to $149367.0 in 2025, then jumped by 135.27% to $351418.0 in 2026.
- Business Quant data shows VERU's Net Income at $351418.0 in Q1 2026, $149367.0 in Q3 2025, and -$9719.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 351,418.00 |
| Sep 30, 2025 | 149,367.00 |
| Jun 30, 2025 | -9,719.00 |
| Mar 31, 2025 | -49,226.00 |
| Dec 31, 2024 | -7.14 Mn |
| Sep 30, 2024 | 18,778.00 |
| Jun 30, 2024 | -628,818.00 |
| Mar 31, 2024 | -1.32 Mn |
| Dec 31, 2023 | -608,598.00 |
| Sep 30, 2023 | -7.45 Mn |
| Jun 30, 2023 | -12.26 Mn |
| Mar 31, 2023 | -33.79 Mn |
| Dec 31, 2022 | -30.63 Mn |
| Sep 30, 2022 | -42.20 Mn |
| Jun 30, 2022 | -17.43 Mn |
| Mar 31, 2022 | -14.18 Mn |
| Dec 31, 2021 | -6.16 Mn |
| Sep 30, 2021 | -3.22 Mn |
| Jun 30, 2021 | -4.40 Mn |
| Mar 31, 2021 | -2.83 Mn |